ND HB1422

Effective August 1, 2013, drug prior authorization requests must be accessible through providers' electronic prescribing software and accepted electronically by payers, insurance companies, or pharmacy benefit managers; facsimiles do not qualify as electronic transmission.

Electronic transmission devices used to communicate prescriptions cannot use advertising, commercial messaging, or popup advertisements to influence prescribing decisions at the point of care, and any such communications must comply with FDA requirements and product labeling.

Electronic prescribing software may display payer formulary information only if the software does not preclude or obstruct a prescriber's or patient's ability to select any particular pharmacy or pharmaceutical.

The health information technology advisory committee must establish an outline during the 2011-12 interim on standardizing drug prior authorization request transactions between providers and payers to maximize administrative efficiency and align with national standards.

The health information technology advisory committee must submit a report to legislative management by June 30, 2012, regarding the standardization outline for drug prior authorization request transactions.